New ways to measure vision quality of life
Part of Brain & nervous system clinical trials.
This study tests new tools, like a tablet and VR headset, to see if they can better measure how your vision affects your daily life. You might join if you have a nerve or retina disease that affects your sight.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have a disease that affects the optic nerve or retina, like glaucoma or multiple sclerosis.
- You can use a tablet and a VR headset without help.
- You agree to take part and sign a consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This early-stage study uses virtual reality tasks to check how well a person can move and function using their eyesight. It may help researchers measure vision abilities in a way that could guide future care for retinal disease.
This study looks at how life quality changes or is measured in adults who have vision problems and are in specialized vision rehabilitation. You may be asked to answer questionnaires to help the research team understand your experience.
This study is looking at how people with inherited retinal disease that affects peripheral vision see and move around. It will test a new way to measure vision and navigation to see if it can help doctors understand how the disease affects daily life.
This trial tests how well an EyeCTester smartphone app can measure vision blind spots and distorted vision compared with standard eye tests. If you qualify, you’ll do short near-vision and “Amsler grid” style tasks in the clinic to help confirm the app is accurate.
This study tests a new virtual reality device to measure your field of vision (how well you see at the edges). It will compare the VR test to the standard bowl test. If you have healthy eyes or glaucoma, you may be able to join.
This study uses virtual reality tests to see if they can measure vision changes in people with age-related macular degeneration (AMD), a condition that affects central vision. It compares results from healthy volunteers and people at different stages of AMD.
Hear when a new Neurodegenerative Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.